Henry Ford Health — Novi, Michigan

Public research footprint of Henry Ford Health, compiled from the ClinicalTrials.gov public registry.

138

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma · Lung Non-Squamous Non-Small Cell Carcinoma · Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma

Recently updated registry entries

NCT04310007 — Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune… (Active Not Recruiting)
NCT03191149 — Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change (Recruiting)
NCT02048813 — Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Henry Ford Health?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.